Hyperphosphorylated tau-based Alzheimer’s Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity is a research paper published in SLAS DISCOVERY (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH National Institute of General Medical Sciences
Grant: RO1GM098285
National Institute on Aging
Grant: R44AG057274
National Institute on Aging
Grant: R01AG062435
National Institute on Aging
Grant: RF1AG077475
NIGMS NIH HHS
Grant: R01 GM098285
NINDS NIH HHS
Grant: R01 NS135693
NIA NIH HHS
Grant: R01 AG077475
National Institutes of Health
Grant: 2R44AG057274-02
Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor
National Institutes of Health
Grant: 1R01AG062435-01
Hyperphosphorylated tau aggregation-based Alzheimer’s disease early drug discovery
National Institutes of Health
Grant: 1RF1AG077475-01
Hyperphosphorylated tau and the molecular mechanisms of tauopathy
National Institutes of Health
Grant: 5R01GM098285-02
Synthesis of Complex Carbohydrates.
National Institutes of Health
FWCI
2.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords